RadNet, Inc. (RDNT)

Market Cap	4.18B
Revenue (ttm)	1.87B
Net Income (ttm)	-32.35M
Shares Out	75.03M
EPS (ttm)	-0.44
PE Ratio	n/a
Forward PE	104.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	555,523
Open	55.71
Previous Close	55.62
Day's Range	54.50 - 56.01
52-Week Range	45.00 - 93.65
Beta	1.44
Analysts	Strong Buy
Price Target	69.60 (+25.07%)
Earnings Date	Aug 6, 2025

About RDNT

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jul 1, 1986
• Employees: 9,000
• Stock Exchange: NASDAQ
• Ticker Symbol: RDNT
• Website: https://www.radnet.com

Financial Performance

In 2024, RadNet's revenue was $1.83 billion, an increase of 13.18% compared to the previous year's $1.62 billion. Earnings were $2.79 million, a decrease of -8.25%.

Analyst Summary

According to 5 analysts, the average rating for RDNT stock is "Strong Buy." The 12-month stock price target is $69.6, which is an increase of 25.07% from the latest price.

Price Target

$69.6

(25.07% upside)

Analyst Consensus: Strong Buy